Back
Trevi Therapeutics, Inc. Stock Predictions
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
61
TRVI
Trevi Therapeutics, Inc.
Last Price:
$13.47
Seasonality Move:
49.5%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiTrevi Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Trevi Therapeutics, Inc. has on average historically risen by 90.6% based on the past 6 years of stock performance.
-
Trevi Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Trevi Therapeutics, Inc. Stock Undervalued?The current Trevi Therapeutics, Inc. [TRVI] share price is $13.47. The Score for TRVI is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
TRVI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Trevi Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Trevi Therapeutics, Inc. has on average historically risen by 90.6% based on the past 6 years of stock performance.
Trevi Therapeutics, Inc. Stock Rating
Buy
61
Trevi Therapeutics, Inc. (TRVI)
is a Buy
Is Trevi Therapeutics, Inc. overpriced?
-
Trevi Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Trevi Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
trevitherapeutics.com
52-Week Data
52-Week High:
14.00
52-Week Low:
2.36
Prediction Charts
Market Cap:
1.7B
Price in USD:
13.47
Volume:
2.6M
Beta:
0.53
Technical Analysis
SMA50:
10.98
SMA100:
9.33
SMA200:
7.70
52-Wk Change:
418.08%
Stock Predictions
-
Is Trevi Therapeutics, Inc. stock public?Yes, Trevi Therapeutics, Inc. is a publicly traded company.
-
What is the Trevi Therapeutics, Inc. stock quote today?The Trevi Therapeutics, Inc. stock price is 13.47 USD today.
-
How to buy Trevi Therapeutics, Inc. stock online?You can buy Trevi Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-17 | 11.34 | 11.35 | 11.67 | 11.06 |
| Nov-18 | 11.23 | 11.31 | 11.48 | 10.94 |
| Nov-19 | 11.31 | 11.04 | 11.42 | 10.78 |
| Nov-20 | 11.27 | 10.65 | 11.32 | 10.62 |
| Nov-21 | 10.59 | 10.99 | 11.21 | 10.46 |
| Nov-24 | 10.99 | 11.41 | 11.46 | 10.80 |
| Nov-25 | 11.45 | 11.36 | 11.64 | 11.21 |
| Nov-26 | 11.48 | 13.29 | 13.73 | 11.28 |
| Nov-28 | 13.28 | 13.19 | 13.78 | 13.08 |
| Dec-1 | 13.07 | 13.30 | 13.33 | 12.75 |
| Dec-2 | 13.30 | 13.35 | 13.91 | 13.05 |
| Dec-3 | 13.27 | 13.70 | 13.93 | 13.08 |
| Dec-4 | 13.48 | 13.47 | 14.00 | 13.35 |
| Dec-5 | 13.55 | 13.47 | 13.74 | 13.25 |
Trevi Therapeutics, Inc. Earnings
Trevi Therapeutics, Inc. Earnings Report: Per Share Trevi Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Trevi Therapeutics, Inc. Forecast Revenue Growth
Trevi Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Trevi Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and a decrease next year of $0.09 per share.
* Trevi Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.